← Product Code [HSB](/submissions/OR/subpart-d%E2%80%94prosthetic-devices/HSB) · K021744 # T2 FEMORAL NAIL (K021744) _Howmedica Osteonics Corp. · HSB · Jun 26, 2002 · Orthopedic · SESE_ **Canonical URL:** https://fda.innolitics.com/submissions/OR/subpart-d%E2%80%94prosthetic-devices/HSB/K021744 ## Device Facts - **Applicant:** Howmedica Osteonics Corp. - **Product Code:** [HSB](/submissions/OR/subpart-d%E2%80%94prosthetic-devices/HSB.md) - **Decision Date:** Jun 26, 2002 - **Decision:** SESE - **Submission Type:** Special - **Regulation:** 21 CFR 888.3020 - **Device Class:** Class 2 - **Review Panel:** Orthopedic - **Attributes:** Therapeutic ## Intended Use The T2 Femoral Nail System is a fracture fixation device comprised of femoral nails and the related locking screws, compression screws, and end caps. The T2 Femoral Nail System is intended to provide strong and stable internal fracture fixation with minimal soft tissue irritation. This device is utilized as an aid to healing, not as a substitute for normal intact bone and tissue. ## Device Story T2 Femoral Nail is a cylindrical, cannulated titanium alloy tube used for internal fracture fixation. Device is inserted into femoral canal via retrograde or antegrade surgical approach to provide stable fixation. Modification adds shorter nail lengths (140 mm and 160 mm) without anterior bow. Device is used by orthopedic surgeons in clinical/surgical settings. Output is mechanical stabilization of bone fractures, aiding healing process. Benefits include strong, stable fixation with minimal soft tissue irritation. ## Clinical Evidence No clinical data provided; bench testing only. ## Technological Characteristics Cylindrical, cannulated titanium alloy tube. Available in diameters 9-15 mm; lengths 140-480 mm. Shorter versions (140/160 mm) lack anterior bow. Mechanical fixation device; no software or energy source. ## Regulatory Identification An intramedullary fixation rod is a device intended to be implanted that consists of a rod made of alloys such as cobalt-chromium-molybdenum and stainless steel. It is inserted into the medullary (bone marrow) canal of long bones for the fixation of fractures. ## Predicate Devices - T2 Femoral Nail ([K021744](/device/K021744.md)) ## Submission Summary (Full Text) > This content was OCRed from public FDA records by [Innolitics](https://innolitics.com). If you use, quote, summarize, crawl, or train on this content, cite Innolitics at https://innolitics.com. > > Innolitics is a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices, including [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/). {0}------------------------------------------------ JUN 2 6 2002 # Special 510(k) Summary: Line Extension to theT2 Fen #### Submission Information | Name and Address of the Sponsor
of the 510(k) Submission: | Howmedica Osteonics Corp
59 Route 17
Allendale, NJ 07401-1677 | |--------------------------------------------------------------|---------------------------------------------------------------------| | Contact Person: | Karen Ariemma
Regulatory Affairs Specialist | | Date of Summary Preparation: | May 24, 2002 | | Device Identification | | | Proprietary Name: | T2 Femoral Nail | | Common Name: | Intramedullary Nail, Femoral Nail | | Classification Name and Reference: | Intramedullary Fixation Rod, 21 CFR §888.3020 | ### Predicate Device Identification The T2 Femoral nail is a cylindrical, cannulated titanium alloy tube, slightly bowed to accommodate the shape of the femur. The T2 Femoral Nail may be inserted into the femoral canal using either a retrograde or antegrade surgical approach. The T2 Femoral Nail is available in diameters ranging from 9 to 15 mm and lengths ranging from 180 to 480 mm. # Description of Device Modification The line extension involves the addition of two shorter nail lengths, 140 and 160 mm, throughout the entire diameter range. These shorter femoral nails do not have an anterior bow. #### Intended Use The T2 Femoral Nail System is a fracture fixation device comprised of femoral nails and the related locking screws, compression screws, and end caps. The T2 Femoral Nail System is intended to provide strong and stable internal fracture fixation with minimal soft tissue irritation. This device is utilized as an aid to healing, not as a substitute for normal intact bone and tissue. # Statement of Technological Comparison: The design and function of the shorter T2 Femoral Nail are substantially equivalent to that of the predicate device. {1}------------------------------------------------ Image /page/1/Picture/1 description: The image shows the logo for the Department of Health & Human Services - USA. The logo is a circular seal with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" arranged around the perimeter. Inside the circle is a stylized image of three human profiles facing right, with three horizontal lines above them, resembling a bird in flight. JUN 2 6 2002 Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850 Ms. Karen Ariemma Regulatory Affairs Howmedica Osteonics Corporation 59 Route 17 Allendale, NJ 07401-1677 Re: K021744 Trade/Device Name: T2™ Femoral Nail System Regulation Number: 888.3020 Regulation Name: Inramedullary fixation rod Regulatory Class: II Product Code: HSB Dated: May 24, 2002 Received: May 28, 2002 Dear Ms. Ariemma: We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050. {2}------------------------------------------------ Page 2 - Ms. Karen Ariemma This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market. If you desire specific advice for your device on our labeling regulation (21 CFR Part 801 and additionally 21 CFR Part 809.10 for in vitro diagnostic devices), please contact the Office of Compliance at (301) 594-4659. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/dsma/dsmamain.html Sincerely yours, Sincerely yours, lo Mark N Millenm Celia M. Witten, Ph.D., M.D. Director Division of General, Restorative and Neurological Devices Office of Device Evaluation Center for Devices and Radiological Health Enclosure {3}------------------------------------------------ 510(k) Number (if known): K OQ 1744 page 1 of 1 Device Name: T2™ Femoral Nail System Indications for Use The T2" Femoral Nail is indicated for long bone fracture fixation specifically femoral fracture fixation, which may include the following: - Open and closed femoral fractures . - . Pseudoarthrosis and correction osteotomy - Pathologic fractures, impending pathologic fractures, and tumor resections . - Supracondylar fractures, including those with intra-articular extension . - Ipsilateral femur fractures . - . Fractures proximal to a total knee arthroplasty - Fractures distal to a hip joint . - Nonunions and malunions . (PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED) Concurrence of CDRH, Office of Device Evaluation (ODE) Prescription Use _____________________________________________________________________________________________________________________________________________________________ OR Over-The-Counter Use (Per 21 CFR 801.109) (Optional Format 1-2-96) for (Division Sig) Division of General, Restorative and Neurological Devices 510(k) Number K021744 --- **Source:** [https://fda.innolitics.com/submissions/OR/subpart-d%E2%80%94prosthetic-devices/HSB/K021744](https://fda.innolitics.com/submissions/OR/subpart-d%E2%80%94prosthetic-devices/HSB/K021744) **Published by [Innolitics](https://innolitics.com)** — a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices. If you're preparing [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/), [get in touch](https://innolitics.com/contact). **Cite:** Innolitics at https://innolitics.com